Skip to main content
. 2024 Dec 30;3(1):qyae141. doi: 10.1093/ehjimp/qyae141

Figure 1.

Figure 1

Patient flowchart. Patients with and without cardiac amyloidosis were divided into 2:1 for the model development and evaluation.